Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Nociceptin/Orphanin Fq in inflammation and remodeling of the small airways in experimental model of airway hyperresponsiveness.

Tartaglione G, Spaziano G, Sgambato M, Russo TP, Liparulo A, Esposito R, Mirra S, Filosa R, Roviezzo F, Polverino F, D'Agostino B.

Physiol Rep. 2018 Oct;6(20):e13906. doi: 10.14814/phy2.13906.

2.

Function of Armcx3 and Armc10/SVH Genes in the Regulation of Progenitor Proliferation and Neural Differentiation in the Chicken Spinal Cord.

Mirra S, Ulloa F, Gutierrez-Vallejo I, Martì E, Soriano E.

Front Cell Neurosci. 2016 Mar 3;10:47. doi: 10.3389/fncel.2016.00047. eCollection 2016.

3.

The Armc10/SVH gene: genome context, regulation of mitochondrial dynamics and protection against Aβ-induced mitochondrial fragmentation.

Serrat R, Mirra S, Figueiro-Silva J, Navas-Pérez E, Quevedo M, López-Doménech G, Podlesniy P, Ulloa F, Garcia-Fernàndez J, Trullas R, Soriano E.

Cell Death Dis. 2014 Apr 10;5:e1163. doi: 10.1038/cddis.2014.121.

4.

The mixture of "ecstasy" and its metabolites impairs mitochondrial fusion/fission equilibrium and trafficking in hippocampal neurons, at in vivo relevant concentrations.

Barbosa DJ, Serrat R, Mirra S, Quevedo M, de Barreda EG, Àvila J, Ferreira LM, Branco PS, Fernandes E, Lourdes Bastos Md, Capela JP, Soriano E, Carvalho F.

Toxicol Sci. 2014 Jun;139(2):407-20. doi: 10.1093/toxsci/kfu042. Epub 2014 Mar 4.

PMID:
24595818
5.

MDMA impairs mitochondrial neuronal trafficking in a Tau- and Mitofusin2/Drp1-dependent manner.

Barbosa DJ, Serrat R, Mirra S, Quevedo M, Gómez de Barreda E, Avila J, Fernandes E, Bastos Mde L, Capela JP, Carvalho F, Soriano E.

Arch Toxicol. 2014 Aug;88(8):1561-72. doi: 10.1007/s00204-014-1209-7. Epub 2014 Feb 13.

PMID:
24522274
6.

Cellular and subcellular localization of PKMζ.

Hernández AI, Oxberry WC, Crary JF, Mirra SS, Sacktor TC.

Philos Trans R Soc Lond B Biol Sci. 2013 Dec 2;369(1633):20130140. doi: 10.1098/rstb.2013.0140. Print 2014 Jan 5.

7.

The non-canonical Wnt/PKC pathway regulates mitochondrial dynamics through degradation of the arm-like domain-containing protein Alex3.

Serrat R, López-Doménech G, Mirra S, Quevedo M, Garcia-Fernàndez J, Ulloa F, Burgaya F, Soriano E.

PLoS One. 2013 Jul 2;8(7):e67773. doi: 10.1371/journal.pone.0067773. Print 2013.

8.

Catenation of calixarene annulus.

Gaeta C, Talotta C, Mirra S, Margarucci L, Casapullo A, Neri P.

Org Lett. 2013 Jan 4;15(1):116-9. doi: 10.1021/ol303142c. Epub 2012 Dec 18.

PMID:
23286391
9.

The Eutherian Armcx genes regulate mitochondrial trafficking in neurons and interact with Miro and Trak2.

López-Doménech G, Serrat R, Mirra S, D'Aniello S, Somorjai I, Abad A, Vitureira N, García-Arumí E, Alonso MT, Rodriguez-Prados M, Burgaya F, Andreu AL, García-Sancho J, Trullas R, Garcia-Fernàndez J, Soriano E.

Nat Commun. 2012 May 8;3:814. doi: 10.1038/ncomms1829.

PMID:
22569362
10.

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.

Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, Trojanowski JQ, Vinters HV, Montine TJ.

Alzheimers Dement. 2012 Jan;8(1):1-13. doi: 10.1016/j.jalz.2011.10.007.

11.

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.

Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT; National Institute on Aging; Alzheimer’s Association.

Acta Neuropathol. 2012 Jan;123(1):1-11. doi: 10.1007/s00401-011-0910-3. Epub 2011 Nov 20.

12.

Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer's disease.

Shao CY, Mirra SS, Sait HB, Sacktor TC, Sigurdsson EM.

Acta Neuropathol. 2011 Sep;122(3):285-92. doi: 10.1007/s00401-011-0843-x. Epub 2011 Jun 1.

13.

NESCA: a new NEMO/IKKgamma and TRAF6 interacting protein.

Napolitano G, Mirra S, Monfregola J, Lavorgna A, Leonardi A, Ursini MV.

J Cell Physiol. 2009 Aug;220(2):410-7. doi: 10.1002/jcp.21782.

PMID:
19365808
14.

Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years.

Fillenbaum GG, van Belle G, Morris JC, Mohs RC, Mirra SS, Davis PC, Tariot PN, Silverman JM, Clark CM, Welsh-Bohmer KA, Heyman A.

Alzheimers Dement. 2008 Mar;4(2):96-109. doi: 10.1016/j.jalz.2007.08.005.

15.

Aberrantly regulated proteins in frontotemporal dementia.

Schweitzer K, Decker E, Zhu L, Miller RE, Mirra SS, Spina S, Ghetti B, Wang M, Murrell J.

Biochem Biophys Res Commun. 2006 Sep 22;348(2):465-72. Epub 2006 Jul 28.

PMID:
16890190
16.

Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease.

Shiarli AM, Jennings R, Shi J, Bailey K, Davidson Y, Tian J, Bigio EH, Ghetti B, Murrell JR, Delisle MB, Mirra S, Crain B, Zolo P, Arima K, Iseki E, Murayama S, Kretzschmar H, Neumann M, Lippa C, Halliday G, Mackenzie J, Khan N, Ravid R, Dickson D, Wszolek Z, Iwatsubo T, Pickering-Brown SM, Mann DM.

Neuropathol Appl Neurobiol. 2006 Aug;32(4):374-87.

PMID:
16866983
17.

Atypical protein kinase C in neurodegenerative disease II: PKCiota/lambda in tauopathies and alpha-synucleinopathies.

Shao CY, Crary JF, Rao C, Sacktor TC, Mirra SS.

J Neuropathol Exp Neurol. 2006 Apr;65(4):327-35.

PMID:
16691114
18.

Atypical protein kinase C in neurodegenerative disease I: PKMzeta aggregates with limbic neurofibrillary tangles and AMPA receptors in Alzheimer disease.

Crary JF, Shao CY, Mirra SS, Hernandez AI, Sacktor TC.

J Neuropathol Exp Neurol. 2006 Apr;65(4):319-26.

PMID:
16691113
19.

Nuclear pore complex proteins in Alzheimer disease.

Sheffield LG, Miskiewicz HB, Tannenbaum LB, Mirra SS.

J Neuropathol Exp Neurol. 2006 Jan;65(1):45-54.

PMID:
16410748
20.

Recognition: Robert Terry.

Mirra SS.

Alzheimers Dement. 2005 Jul;1(1):79. doi: 10.1016/j.jalz.2005.06.017. No abstract available.

PMID:
19595825
21.

Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.

Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I; Office of Rare Diseases of the National Institutes of Health.

J Neuropathol Exp Neurol. 2002 Nov;61(11):935-46.

PMID:
12430710
22.

Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis.

Atzori C, Ghetti B, Piva R, Srinivasan AN, Zolo P, Delisle MB, Mirra SS, Migheli A.

J Neuropathol Exp Neurol. 2001 Dec;60(12):1190-7.

PMID:
11764091
23.

Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study.

Wolf DS, Gearing M, Snowdon DA, Mori H, Markesbery WR, Mirra SS.

Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13(4):226-31.

PMID:
10609672
24.

The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series.

Tsuang D, Larson EB, Bowen J, McCormick W, Teri L, Nochlin D, Leverenz JB, Peskind ER, Lim A, Raskind MA, Thompson ML, Mirra SS, Gearing M, Schellenberg GD, Kukull W.

Arch Neurol. 1999 Dec;56(12):1489-95.

PMID:
10593304
25.

Apolipoprotein E and the neuropathology of Alzheimer's disease.

Mirra SS.

Hum Pathol. 1999 Oct;30(10):1125-7. No abstract available.

PMID:
10534156
26.

Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX.

Heyman A, Fillenbaum GG, Gearing M, Mirra SS, Welsh-Bohmer KA, Peterson B, Pieper C.

Neurology. 1999 Jun 10;52(9):1839-44.

PMID:
10371532
27.

Tau pathology in a family with dementia and a P301L mutation in tau.

Mirra SS, Murrell JR, Gearing M, Spillantini MG, Goedert M, Crowther RA, Levey AI, Jones R, Green J, Shoffner JM, Wainer BH, Schmidt ML, Trojanowski JQ, Ghetti B.

J Neuropathol Exp Neurol. 1999 Apr;58(4):335-45.

PMID:
10218629
28.

Neurofibrillary pathology in Alzheimer disease with Lewy bodies: two subgroups.

Gearing M, Lynn M, Mirra SS.

Arch Neurol. 1999 Feb;56(2):203-8.

PMID:
10025425
29.

Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease.

Heyman A, Fillenbaum GG, Welsh-Bohmer KA, Gearing M, Mirra SS, Mohs RC, Peterson BL, Pieper CF.

Neurology. 1998 Jul;51(1):159-62. Erratum in: Neurology 1998 Dec;51(6):1809.

PMID:
9674796
30.

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM.

Arch Neurol. 1998 Mar;55(3):326-35.

PMID:
9520006
31.

Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.

Mayeux R, Saunders AM, Shea S, Mirra S, Evans D, Roses AD, Hyman BT, Crain B, Tang MX, Phelps CH.

N Engl J Med. 1998 Feb 19;338(8):506-11. Erratum in: N Engl J Med 1998 Apr 30;338(18):1325.

32.

A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase.

Melov S, Schneider JA, Day BJ, Hinerfeld D, Coskun P, Mirra SS, Crapo JD, Wallace DC.

Nat Genet. 1998 Feb;18(2):159-63.

PMID:
9462746
33.
34.

Apolipoprotein E genotypes in a neuropathological series from the Consortium to Establish a Registry for Alzheimer's Disease.

Welsh-Bohmer KA, Gearing M, Saunders AM, Roses AD, Mirra S.

Ann Neurol. 1997 Sep;42(3):319-25.

PMID:
9307253
35.

Neuropathologic assessment of Alzheimer's disease.

Mirra SS, Gearing M, Nash F.

Neurology. 1997 Sep;49(3 Suppl 3):S14-6. No abstract available.

PMID:
9310508
36.

Brain infarction and the clinical expression of Alzheimer disease.

Mirra SS, Gearing M.

JAMA. 1997 Jul 9;278(2):113; author reply 114. No abstract available.

PMID:
9214519
38.

Presenilin-1 protein expression in familial and sporadic Alzheimer's disease.

Levey AI, Heilman CJ, Lah JJ, Nash NR, Rees HD, Wakai M, Mirra SS, Rye DB, Nochlin D, Bird TD, Mufson EJ.

Ann Neurol. 1997 Jun;41(6):742-53.

PMID:
9189035
39.

Corticobasal degeneration: neuropathologic and clinical heterogeneity.

Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS.

Neurology. 1997 Apr;48(4):959-69.

PMID:
9109885
40.
41.

beta-Amyloid (A beta) deposition in the brains of aged orangutans.

Gearing M, Tigges J, Mori H, Mirra SS.

Neurobiol Aging. 1997 Mar-Apr;18(2):139-46.

PMID:
9258890
42.

Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases.

Hulette C, Nochlin D, McKeel D, Morris JC, Mirra SS, Sumi SM, Heyman A.

Neurology. 1997 Mar;48(3):668-72.

PMID:
9065545
43.

Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease.

Ishii K, Tamaoka A, Mizusawa H, Shoji S, Ohtake T, Fraser PE, Takahashi H, Tsuji S, Gearing M, Mizutani T, Yamada S, Kato M, St George-Hyslop PH, Mirra SS, Mori H.

Brain Res. 1997 Feb 14;748(1-2):250-2.

PMID:
9067471
44.
45.

A beta40 is a major form of beta-amyloid in nonhuman primates.

Gearing M, Tigges J, Mori H, Mirra SS.

Neurobiol Aging. 1996 Nov-Dec;17(6):903-8.

PMID:
9363802
46.

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH.

Neurology. 1996 Nov;47(5):1113-24. Review.

PMID:
8909416
47.

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV.

Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, Heyman A.

Neurology. 1996 Jun;46(6):1592-6.

PMID:
8649554
48.

Abeta-peptide length and apolipoprotein E genotype in Alzheimer's disease.

Gearing M, Mori H, Mirra SS.

Ann Neurol. 1996 Mar;39(3):395-9.

PMID:
8602762
49.

Regional variation in the distribution of apolipoprotein E and A beta in Alzheimer's disease.

Gearing M, Schneider JA, Robbins RS, Hollister RD, Mori H, Games D, Hyman BT, Mirra SS.

J Neuropathol Exp Neurol. 1995 Nov;54(6):833-41.

PMID:
7595656
50.

Supplemental Content

Support Center